Vaxcyte, Inc. Common Stock (PCVX) Stock
NASDAQ · PCVX
58.92
Fundamentals
Market cap
$8.65B
Price / Earnings ratio
-8.1x
Price / Sales ratio
N/A
Price / Book ratio
3.1x
Return on assets
-0.3%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Vaxcyte, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees507
CEOMr. Grant E. Pickering M.B.A.
IPO DateJun 12, 2020
HeadquartersSan Carlos, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Grant E. Pickering M.B.A. | Co-Founder, CEO & Director | 1968 |
| Mr. Andrew L. Guggenhime M.B.A. | President & CFO | 1968 |
| Mr. James T. Wassil M.B.A., M.S. | Executive VP & COO | 1969 |
| Mr. Harp Dhaliwal M.B.A. | Chief Technical Operations Officer | 1973 |
| Mr. Mikhail Eydelman J.D. | Senior VP & General Counsel | 1981 |
| Dr. Jeff Fairman Ph.D. | Co-Founder & VP of Research | 1964 |
| Ms. Elvia Cowan | Senior VP of Finance & Chief Accounting Officer | 1973 |
| Mr. Jeff Macdonald | Executive Director of Investor Relations | — |
| Mr. David McAvoy J.D. | Chief Legal Officer, Chief Compliance Officer & Corporate Secretary | — |
| Ms. Whitney Jones | Chief People Officer | — |
Fundamentals
Valuation
Market cap$8.65B
Price-to-sales ratioN/A
Price-to-book value3.14
Price-earnings ratio-8.10
Return on Equity-33.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-7.63
Income Statement
Average volume1,243,790
EBITDA$-920.69M
1 year high (52w)$65.00
1 year low (52w)$31.51
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



